The Wegovy pill is expected to hit the market in January, joining injectable GLP-1 drugs that have transformed obesity treatment. One form you swallow, the other you inject. What else is different?

Novo Nordisk offers Wegovy weight-loss pill in the US at $149 per month for self-pay patients, expanding access to oral ...

Weight-loss injections are dominating the market: Where will GLP-1 pills fit in? Glucagon-like peptide-1 (GLP-1) medications have emerged as powerful tools for weight loss. So far, injectable options ...

Semaglutide, the active ingredient in Ozempic and Wegovy, is a glucagon-like peptide-1 (GLP-1) receptor agonist taken as a once-weekly injection. It’s administered with a tiny needle that punctures ...

As of February 2025, the semaglutide injection (Ozempic, Wegovy) shortage was resolved. As a result, compounded semaglutide injections are largely being phased out. While they may still be available ...

PLAINSBORO, N.J., March 29, 2025 /PRNewswire/ -- Novo Nordisk today presented results from STRIDE, its phase 3b trial investigating the effects of once-weekly Ozempic ® (semaglutide) injection 1 mg in ...

FRESNO, Calif. (KFSN) -- Social media has an abundance of weight loss videos, from the latest diet trends to the most popular fitness programs. But for some like Amber Contino, nutritious foods and ...

Switching From Tirzepatide to semaglutide for weight loss? This article was reviewed by Lynn Marie Morski, MD, JD. Key takeaways: You can switch from tirzepatide to ...

Drug major Sun Pharmaceutical Industries Limited has received a key regulatory clearance from the Subject Expert Committee ...

In an exchange filing, the Pune-based drugmaker said it is the first Indian company to exclusively distribute and ...